AUS
NZ
UK
CA
USA
IND
Healthcare
Faron Pharmaceuticals Appoints Dr. Petri Bono as New Chief Medical Officer
August 06, 2024 10:48 AM BST| By Team Kalkine MediaFaron Pharmaceuticals Ltd. (AIM:FARN), a clinical-stage biopharmaceutical company focused on pioneering CLEVER-1 receptor-targeting approaches to enhance anti-tumor immunity in treatment-resistant cancers, has announced the appointment of Dr. Petri B...
.png)
GSK Triumphs in Illinois Court, Jury Finds No Cancer Link to Ranitidine
August 06, 2024 10:17 AM BST| By Team Kalkine MediaGSK plc (LSE/NYSE:GSK) announced today that a jury in Illinois state court has ruled in its favor in the Joiner case. This decision is a significant victory for the company, reinforcing its stance that ranitidine does not pose a cancer risk.,Scientif...
Why Johnson Matthey’s High P/E Ratio Deserves Closer Watch?
August 05, 2024 01:48 PM BST| By Team Kalkine MediaJohnson Matthey PLC’s (LSE: JMAT) P/E ratio of 26.6x is notably higher than the UK market average of around 16x. This ratio indicates that investors have expectations for the company's future performance, as a high P/E ratio generally reflects a prem...
IXICO Appoints New CEO, Bram Goorden
August 05, 2024 09:27 AM BST| By Team Kalkine MediaIXICO plc (AIM:IXI), a leading precision analytics company specializing in neuroscience, is pleased to announce the appointment of Bram Goorden as Chief Executive Officer (CEO), effective from 19 August 2024. Bram will succeed Giulio Cerroni, who is...
_08_02_2023_11_21_17_866226.jpg)
hVIVO to Cancel Euronext Growth Listing to Focus on AIM Market
August 05, 2024 09:23 AM BST| By Team Kalkine MediahVIVO plc (AIM:HVO), a leading specialist contract research organization (CRO) renowned for its expertise in human challenge clinical trials for infectious and respiratory diseases, has announced its decision to cancel its listing on Euronext Growth....
Haleon Announces Increase in 1H 2024 Interim Dividend
August 01, 2024 10:42 AM BST| By Team Kalkine MediaHaleon plc (LSE/NYSE:,HLN,) has announced its half-year results for the period ending 31 December 2024, along with a significant increase in its interim dividend. Consistent with the company's previous guidance to grow the dividend in line with earni...
Smith+Nephew Reports 1H and 2Q Results, Maintains 2024 Guidance
August 01, 2024 10:39 AM BST| By Team Kalkine MediaSmith+Nephew (LSE: SN, NYSE:,SNN,), a global medical technology company, reported its financial results for the second quarter and the first half ended June 29, 2024. The company demonstrated robust growth across key financial metrics, underscoring i...
Croda International Share Price Falls 62% Today. Here’s Why.
July 31, 2024 06:35 PM BST| By Team Kalkine MediaCroda International (,LSE:CRDA,), a chemicals company renowned for its high-quality products used in various industries, has seen its share price decline by 62% from its 2021 highs. The latest trading update initially painted a bleak picture, causing...
GSK Gains Limelight With Upgraded 2024 Guidance
July 31, 2024 03:53 PM BST| By Team Kalkine MediaGSK (,LSE:GSK,) has delivered a strong financial performance for the second quarter of 2024, demonstrating substantial growth across its portfolio. The company achieved total sales of £7.9 billion, marking a 13% increase compared to the previous year...
Genedrive (AIM: GDR) Receives FDA Breakthrough Device Designation for MT-RNR1 ID Kit
July 15, 2024 08:04 AM BST| By Team Kalkine MediaGenedrive plc (,AIM: GDR,), a leader in point-of-care pharmacogenetic testing, has announced the receipt of Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Genedrive® MT-RNR1 ID Kit. This designation accelerat...
Scancell Holdings (AIM: SCLP) Strikes Exclusive Evaluation Deal with Major Biotech Firm
June 12, 2024 08:45 AM BST| By Team Kalkine MediaScancell Holdings plc (,AIM: SCLP,), a pioneer in the realm of oncology immunotherapies, has made waves once again with a significant announcement. The company revealed today that a major international biotechnology firm will exclusively evaluate one...
ANGLE plc (AIM: AGL) Announces £8.5 Million Fundraising
June 05, 2024 09:23 AM BST| By Team Kalkine MediaANGLE plc (,AIM: AGL,), a global leader in liquid biopsy technology, has announced plans for a significant fundraising effort aimed at raising approximately £8.5 million. This initiative, comprising a combination of placing, subscription, and open of...
Prescription for Profit: Investing in LON Healthcare Stocks for Healthy Returns and Market Dominance
June 22, 2023 11:26 AM BST| By Team Kalkine MediaThe healthcare sector is a vital and ever-growing industry that offers significant investment opportunities. In this article, we will explore the world of,LON healthcare stocks,and the potential they hold for investors seeking healthy returns and mar...
Healthcare stocks to explore amidst education and health sectors strikes
May 15, 2023 08:56 AM BST| By Manu ShankarHighlights The country was again in crisis as thousands of healthcare and education professionals went on strike, increasing the already prevalent staff and pay crisis. The latest issue was identified following a survey which concluded they could...
Stocks to watch as the UK invests in the fight against deadly diseases
November 14, 2022 02:10 PM GMT| By Rishika RainaOver the course of 3 years, the UK is channelising funds worth £1 billion towards the Global Fund.
Which FTSE health-related stocks to check out right now?
November 14, 2022 11:10 AM GMT| By Abhishek SharmaHighlights:,The Rishi Sunak government will face its first acid test as they gear up for the Autumn budget.,The fiscal statement is all set to be released on 17 November.,Brits are awaiting this week's Autumn budget as Rishi Sunak has pledged that he...
AstraZeneca boosts earnings guidance while demand strengthens
November 10, 2022 01:44 PM GMT| By Rishika RainaAstraZeneca declared its YTD and Q3 2022 results on Thursday.
Key stocks to watch as new clinical trials in UK declines
October 20, 2022 10:15 AM BST| By Rishika Raina• The fall in clinical trials poses a severe threat to the country’s status as a clinical research hub.
PM Truss urged to put billions into social care
September 23, 2022 08:29 AM BST| By Rishika RainaIn her campaign, the PM had pledged to spend £13 billion on social care.
Haleon IPO: GSK gets shareholders' nod; all you should know
July 07, 2022 08:45 AM BST| By Abhishek SharmaHighlights:,GSK Plc on Wednesday received approval from the shareholders for the demerger of its consumer healthcare arm.,The new entity, called Haleon, will be listed on the London Stock Exchange on 18 July.,In what will be the largest listing on th...
